Up to 100,000 on antipsychotics with no review

By Rebecca Thomas2020-01-27T06:06:00

A national strategy is needed to tackle health risks linked to antipsychotic drugs because current policy is letting tens of thousands of people fall through the gaps, commissioners in London are warning.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters
10 expert briefings every fortnight (Premium only)
Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

to HSJ

Already a subscriber? Sign into your account here